Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Dec 14, 2021 10:48pm
134 Views
Post# 34231414

RE:RE:RE:RE:What is (or may be) changing over the next 2 -3 weeks ?

RE:RE:RE:RE:What is (or may be) changing over the next 2 -3 weeks ?

Maybe I'm being hyper critical. Still pissed at management for destroying my portfolio when I trusted them. 

They are in phase 3b of an important FDA trial treating a problem that humanity has few answers for. Despite all of what I consider unbecoming and unsavoury actions... at 50M market cap it's a screaming buy. 

They just need to deliver on their promises... every time. Without excuses. 


Domino55 wrote: Bay Street. Stick to bashing. You are more credible there than being an apologist for the 20 cent share price and pre clinical valuation.

 

<< Previous
Bullboard Posts
Next >>